FATE earnings call for the period ending March 31, 2021.
News & Analysis: Fate Therapeutics
Here's how shares a diversified e-commerce firm, an immunotherapy biotech, and an electronic agreement company can make you rich.
These biotech companies are small, but they have tremendous growth prospects.
FATE earnings call for the period ending December 31, 2020.
The biotech's natural killer cell therapies have real potential.
The biotech reported great news on Friday and Saturday for two of its cancer immunotherapy candidates.
FATE earnings call for the period ending September 30, 2020.
FATE earnings call for the period ending August 6, 2020.
Probably, but it depends on whether the company can deliver on its cost-cutting potential.
Two decades is a long time, but these up-and-coming biopharma companies could earn significantly larger valuations in that span.